Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
First-in-human evaluation of a novel subcutaneous intraosseous vascular access device for outpatient infusions.
Journal: The journal of vascular access
Published: February 06, 2026
Barrett High-Grade Dysplasia and Early Esophageal Adenocarcinoma in Patients With Positive Results on a Nonendoscopic Methylated DNA Biomarker Test.
Journal: Gastroenterology & hepatology
Published: February 02, 2026
Enhancing the Diagnostic Yield of EGD for Diagnosis of Barrett Esophagus Through Methylated DNA Biomarker Triage.
Journal: Gastroenterology & hepatology
Published: May 26, 2025
Real-World Clinical Utility of a Methylated DNA Biomarker Assay on Samples Collected with a Swallowable Capsule-Balloon for Detection of Barrett's Esophagus (BE).
Journal: Medicina (Kaunas, Lithuania)
Published: November 01, 2024
Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population.
Journal: The American journal of gastroenterology
Published: June 23, 2024
Analytical Validation of a DNA Methylation Biomarker Test for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma from Samples Collected Using EsoCheck®, a Non-Endoscopic Esophageal Cell Collection Device.
Journal: Diagnostics (Basel, Switzerland)
Published: June 18, 2024
miR-9 utilizes precursor pathways in adaptation to alcohol in mouse striatal neurons.
Journal: Advances in drug and alcohol research
Published: December 20, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.
Journal: European heart journal
Published: August 02, 2022
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.
Journal: American heart journal
Published: August 02, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026